Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reviews|November 22, 2025
Bone metastases in NSCLC: Modern paradigms in management and supportive careGabriele Minuti, Giorgia Pasqualini, Alice Avancini, et al.
Medicina (Kaunas, Lithuania)|November 11, 2022
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World StudyAlessandro Rizzo, Massimiliano Salati, Giorgio Frega, et al.
The Lancet. Oncology|October 2, 2025
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysisAlessandro Di Federico, Sara Stumpo, Francesco Mantuano, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 18, 2026
Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable NSCLC: a systematic review and meta-analysisPietro Bertoglio, Filippo Tommaso Gallina, Eleonora Balzani, et al.
Lung Cancer (Amsterdam, Netherlands)|October 4, 2025
Attrition with adjuvant, neoadjuvant, and perioperative immunotherapy-based treatment protocols in patients with resectable non-small-cell lung cancer. A meta-analysis of prospective trialsFrancesco Guerrera, Filippo Tommaso Gallina, Eleonora Balzani, et al.
The Journal of Liquid Biopsy|March 3, 2025
Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief reportAndrea De Giglio, Federico Zacchini, Giulia Venturi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2025
Gene Copy Deletion of STK11, KEAP1, and SMARCA4: Clinicopathologic Features and Association With the Outcomes of Immunotherapy With or Without Chemotherapy in Nonsquamous NSCLCMalini M Gandhi, Arielle Elkrief, Catherine Gutierrez Moore, et al.
JCO Precision Oncology|December 5, 2024
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring <i>BRAF</i> Class 3 MutationsAlessandro Di Federico, Stefania Angelicola, Mariateresa Frascino, et al.
Lung Cancer (Amsterdam, Netherlands)|December 22, 2024
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 statusAndrea De Giglio, Dario De Biase, Valentina Favorito, et al.
World Journal of Gastrointestinal Oncology|December 28, 2020
Pancreatic mucinous cystadenocarcinoma in a patient harbouring <i>BRCA1</i> germline mutation effectively treated with olaparib: A case reportMariacristina Di Marco, Riccardo Carloni, Stefania De Lorenzo, et al.
Pageof 11